e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Lung cancer biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A novel
ex vivo
model for the evaluation of hypoxic adaptation in non-small cell lung cancer using surgery explants
K. Leithner, C. Wohlkoenig, E. Stacher, J. Lindenmann, H. Popper, A. Hrzenjak, A. Olschewski, H. Olschewski (Graz, Austria)
Source:
Annual Congress 2009 - Lung cancer biology
Session:
Lung cancer biology
Session type:
E-Communication Session
Number:
295
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Leithner, C. Wohlkoenig, E. Stacher, J. Lindenmann, H. Popper, A. Hrzenjak, A. Olschewski, H. Olschewski (Graz, Austria). A novel
ex vivo
model for the evaluation of hypoxic adaptation in non-small cell lung cancer using surgery explants. Eur Respir J 2009; 34: Suppl. 53, 295
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
A non-small cell lung cancer modelling by endogenous κ-ras manipulation
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005
A novel biologic classification of non-small cell lung cancer
Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology
Year: 2005
The evaluation of surgical results in pT0-pT1 non-small cell lung carcinoma after induction therapy
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011
Does the lung function affect the survival time in patients with resected non-small cell lung cancer?
Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery
Year: 2007
Non-small cell lung cancer with single brain metastasis: the role of surgical treatment
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008
Surgical treatment of nonsmall cell lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=170
Year: 2001
Surgical treatment of N2 non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 39s
Year: 2004
Second line therapy for advanced non-small cell lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Should there be a specific management for large cell neuroendocrine carcinoma?
Source: Annual Congress 2005 - Neuroendocrine tumours of the lung
Year: 2005
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Source: ERS webinar 2021: Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Year: 2021
Adaptation to hypoxia leads to apoptosis resistance to cisplatin in non-small cell lung cancer (NSCLC) cell line
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Expression profiling in hypoxic non-small cell lung cancer explants reveals a four-gene hypoxia signature
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
Different types of bronchial reconstruction in surgical treatment of non-small cell lung cancer. Analysis of our series.
Source: International Congress 2019 – Thoracic surgery
Year: 2019
Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006
Treatment of non-small cell lung cancer (NSCLC) - the state of the art and beyond
Source: International Congress 2017 – State of the art session: "Lung cancer"
Year: 2017
Relevance of an extensive follow-up after surgery for nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1357-1364
Year: 2013
Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018
Efficacy of a pulmonary rehabilitation programme (PRP) after lung resection (LR) for cancer
Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention
Year: 2005
Does long treatment delay affect survival in metastatic non-small cell lung cancer
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept